Can a new device prevent aortic aneurysm rupture?

NCT ID NCT03024554

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This trial is evaluating a new device called the Bifurcated Multilayer Flow Modulator (BMFM) for treating abdominal aortic aneurysms that involve the iliac arteries. The device is designed to be implanted inside the blood vessel to help stabilize the aneurysm and prevent it from rupturing. The study will include adults over 18 with this condition and will track safety and performance over 12 months, focusing on freedom from rupture and aneurysm-related death.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Bifurcated Multilayer Flow Modulator (BMFM) – a device implanted to treat aortic aneurysms
What this could lead to
If successful, this device could offer a less invasive treatment option for abdominal aortic aneurysms, potentially reducing the risk of rupture and improving patient outcomes.
What could go wrong
This is an early-stage trial with a small number of participants, so results may not be conclusive. Risks include device-related complications, aneurysm rupture, or the device not performing as expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC ANEURYSM, ABDOMINAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal aortic aneurysm aortic aneurysm Aortic Aneurysm, Thoracoabdominal

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CMC Coeur et Vaisseaux

    Salé, 11150, Morocco

  • City Hospital Clinic

    Sofia, Bulgaria

  • ELYTIS Hospital: Spital Multidisciplinar şi Policlinică

    Iași, 700010, Romania

  • European Hospital Polisano

    Sibiu, 550172, Romania

  • Hôpitaux IRIS Sud Molière Longchamps

    Brussels, Uccle, 1190, Belgium

  • Maribor University Medical Centre

    Maribor, Slovenia

  • University Medical Centre Ljubljana

    Ljubljana, Slovenia

More trials for these conditions

Other studies related to the condition(s) this trial covers.